What is an “embedded” brain? Johnson & Johnson plans to invest in “neuroplastogen” company Delix; and University of Miami gifts Trump Administration accelerated path to research ibogaine
Plus: Oregon psilocybin program “generally safe,” according to new study, and New Mexico begins accepting psilocybin producer applications
External link. We are not responsible for the content.
Read more ↗More From The Microdose (Berkeley)
What’s the difference between recreational and therapeutic psychedelic use? 5 Questions with experimental psychologist Harriet de Wit
De Wit discusses the difficulty of finding out what a drug does, outside of its context.
Veterans Affairs continues to drive federal psychedelics push; New FDA guidance; and Resilient Pharmaceuticals tries again for MDMA approval
Plus: Pharmaceutical giant Eli Lilly makes a psychedelics acquisition; Cardiovascular safety is top of mind for psych...
Why don’t some people respond to psychedelics? 5 Questions for psychologist Rachel Ham
Ham discusses doing interviews with clinical trial participants who didn’t experience substantial benefits.
Latest News
5 Psychedelic Stories You Should Know This Week
Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states sha...
Orchidaceaen Ethics 1
On acid, ancient philosophy, and the problem of knowing
Horizons: Perspectives on Psychedelics
Please join us this autumn for the 19th Horizons conference on October 15-17 in New York City. This is one of the imp...
Would You Recognize Abuse in Ceremony? If So, What Do You Do?
"The Psychedelic Seeker's Guide" dives into abusive practitioners and what you should do if you witness abuse in psyc...
Weekly Psychedelic Policy Briefing – August 16, 2026
Resilient Pharmaceuticals has resubmitted its New Drug Application for MDMA-assisted therapy for PTSD, without the ne...
Altered ‘state’ vs Altered ‘sense of self’
Psychedelic culture has given us a powerful image of transformation: the self dissolves, the familiar world disappear...